A Look at Ongoing Acute Myeloid Leukemia Phase III Trials
A Look at Ongoing Acute Myeloid Leukemia Phase III Trials from Patient Empowerment Network on Vimeo. What are the acute myeloid leukemia (AML) Phase III clinical trials that are ongoing? […]
Entries by Kara Rayburn
What Does Triplet Therapy in AML Mean for the Future?
What Does Triplet Therapy in AML Mean for the Future? from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about triplet therapy? Dr. […]
A Look at Lower Intensity Chemotherapy in Untreated AML
A Look at Lower Intensity Chemotherapy in Untreated AML from Patient Empowerment Network on Vimeo. Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses whether untreated acute […]
AML Clinical Trials Critical to Treatment Breakthroughs and Improvements
AML Clinical Trials Critical to Treatment Breakthroughs and Improvements from Patient Empowerment Network on Vimeo. Why are acute myeloid leukemia (AML) clinical trials so critical? Dr. Naval Daver from the […]
A Look at Treatment Strategies for High-Risk AML Patients
A Look at Treatment Strategies for High-Risk AML Patients from Patient Empowerment Network on Vimeo. What acute myeloid leukemia (AML) treatments are available for high-risk patients? Dr. Naval Daver from […]
Why Is the Menin Pathway Important in AML?
Why Is the Menin Pathway Important in AML? from Patient Empowerment Network on Vimeo. What should acute myeloid leukemia (AML) patients know about the menin pathway? Dr. Naval Daver from […]
The Importance of the FLT3 Mutation in AML
The Importance of the FLT3 Mutation In AML from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about FLT3 mutation? Dr. Naval Daver […]
What Different AML Subtypes Are More Prevalent in Certain Demographics?
What Different AML Subtypes Are More Prevalent in Certain Demographics? from Patient Empowerment Network on Vimeo. Are some acute myeloid leukemia (AML) subtypes more common in some demographic groups? Dr. […]
AML Treatment Approaches Expand for Older and High-Risk Patients
AML Treatment Approaches Expand for Older and High-Risk Patients from Patient Empowerment Network on Vimeo. How have acute myeloid leukemia (AML) treatment approaches expanded for older and high-risk patients? Dr. […]
What Promising AML Treatments Are Available for Newly Diagnosed Patients?
What Promising AML Treatments Are Available for Newly Diagnosed Patients? from Patient Empowerment Network on Vimeo. What do newly diagnosed acute myeloid leukemia (AML) patients have for promising treatment options? […]
How Can We Address Disparities in AML Among Diverse Populations?
How Can We Address Disparities in AML Among Diverse Populations? from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about care disparities? Dr. […]
Long-Term Effects Acute Myeloid Leukemia Patients Should Know
Long-Term Effects Acute Myeloid Leukemia Patients Should Know from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) need to know about potential long-term effects of treatment? Dr. […]
What Are Some Clinical Predictors for Relapse in Acute Myeloid Leukemia?
What Are Some Clinical Predictors for Relapse in Acute Myeloid Leukemia? from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about risk of […]
What Are the ASH 2022 Takeaways for AML Patients?
What Are the ASH 2022 Takeaways for AML Patients? from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about ASH 2022 updates? Dr. […]
What Does Transfusion Burden Mean in Acute Myeloid Leukemia?
What Does Transfusion Burden Mean in Acute Myeloid Leukemia? from Patient Empowerment Network on Vimeo. What do acute myeloid leukemia (AML) patients need to know about transfusion burden? Dr. Catherine […]
